Fidelity SPDR Advertisement
Home > Boards > US OTC > Medical - Healthcare >

BioCorRx (BICX)

BICX RSS Feed
Add BICX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator MU_Redskin1, Pip611, itsdetatti, Danger Dan
Search This Board:
Last Post: 9/30/2014 9:59:55 AM - Followers: 83 - Board type: Free - Posts Today: 0

 

 

About BioCorRx

Program Overview

BioCorRx (OTCBB: BICX) is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. The company has developed a treatment program that is used by various licensed alcohol addiction clinics throughout the United States.

The program consists of two components:BioCorRx has the worldwide rights (except in Australia and New Zealand) to a highly effective, proprietary implant formulation of the FDA-approved drug, naltrexone. After being surgically implanted by a medical professional, the naltrexone implant significantly reduces cravings for alcohol for as long as a year in some patients, depending on individual metabolism rates.BioCorRx also owns a life coaching program that is tailored specifically to alcoholics. Once a patient has received the implant, they are encouraged to enter the life coaching program to maximize results.

BioCorRx’s revolutionary alcohol treatment program has an 85% success rate as reported by patients in routine telephone and face to face interviews. The implant is administered as an outpatient procedure, and in most cases, patients do not need to miss more than one day of work. They are then able to enter the private life coaching program without co-workers or family members knowing, unless they so choose.

Technology

Naltrexone is a medication that blocks the effects of drugs known as opioids and was approved by the FDA in 1995 for the treatment of alcohol dependence.

Learn more about the side effects of naltrexone.

Naltrexone blocks the parts of the brain that "feel pleasure” when patients use alcohol. When these areas of the brain are blocked, patients feel significantly less cravings for alcohol and even if alcohol is used, the effects of it will be extremely limited - making sobriety the only option. Once medical intervention has reduced the physical need for alcohol, the program goes on to address the patient's psychological needs. The combination of these treatments has resulted in the highest chance of sobriety.

naltrexone implant

While other companies use naltrexone in their treatments, the drug is typically administered in oral or injection form, requiring their patients to be responsible for taking the medication or scheduling an appointment.

While some patients do well with the oral formulation, there is a drawback that it must be taken daily and a patient whose craving becomes overwhelming can obtain the euphoria simply by skipping a dose before resuming abuse. Patients who received the program developed by BioCorRx are treated with a slow release dose that can last up to year in many patients (depending on various factors such as metabolism rates), which gives the patients a higher success rate for the treatment of alcoholism.

The outpatient naltrexone implant procedure can take as little as 20 minutes under local anesthetic in some cases. Most patients can return to work or their daily routine in the same day, without the cravings for alcohol.

Mission, Vision, Values

Mission

BioCorRx is focused on providing leadership and innovation for the treatment of alcoholism by offering a high-quality, comprehensive and cost-effective recovery program that allows patients and their loved ones to celebrate freedom from the cycle of alcohol addiction. Our program is built on a strong foundation of experience and practice, allowing for an improved quality of life for recovering alcoholics.

Vision

BioCorRx strives to be the preeminent, long-term alcohol recovery program used by treatment centers around the world for alcoholics, as well as their family and friends. By providing patients a "Fresh Start" on life, they have the opportunity to live happier, healthier, more productive lives away from the damaging impact of alcohol. We have built an organization that is committed to nurturing research for cutting-edge alcohol recovery technologies and integrating those technologies with comprehensive alcohol recovery treatment programs.

Values

BioCorRx provides the opportunity and tools to treatment centers so they can help patients live happier, healthier, and more productive lives to those suffering from alcohol addiction (as well as their family and friends) by helping them break the addiction cycle and live alcohol-free. We want patients to celebrate freedom from the past and hope for the future. Our team consists of physicians, coaches, founders and management that are committed to providing high-quality services and adherence to ethical care.

Our goal is to give our treatment center partners the ability to deliver our program in a timely, warm and compassionate way to give patients, as well as their families and friends, peace of mind. To achieve this, BioCorRx has built its program around highly-qualified alcohol addiction specialists and effective treatment solutions.

We are committed to quality and continuous improvement in order to meet our partners’ needs for an individualized program dedicated to alcohol addiction recovery.

Investors Overview

BioCorRx is uniquely poised to gain significant market share of the $22 billion annual alcohol treatment market in the US.

More than 7% of the US population ages 18 years and older or 13.8 million Americans have problems with drinking, including 8.1 million people who suffer from alcoholism. And the costs financially are staggering. Alcohol dependency and abuse costs the US over $220 billion a year. For the sake of comparison, this is greater than the amount of money spent to combat cancer ($196 billion) and obesity ($133 billion).

BioCorRx intends to distribute the program to a new clinic in the United States every 60 to 90 days. Clinics using our program are also holding discussions with major health insurance providers to pay for all or a portion of the treatment fees.

Business Model

BioCorRx’s research has discovered that demand for its services are high and that growth in highly marketed segments of the population may be achieved through partnering with additional clinic sites. The company is also exploring the sub-licensing of the program to select regions of the US and internationally.

BioCorRx's goal is to meet its growth targets through licensing opportunities by promoting its naltrexone implant product and counseling service model to existing medical clinics and treatment centers that will purchase the program and/or product from the company. In addition, Fresh Start Private intends to open corporately owned clinics in select key markets where it is deemed appropriate.

Stock Price & Charts

BioCorRx is a fully reporting company. Financial reports and other reports are available for view or by visiting the OTCBB.com online website. Audited financial reports are available quarterly.

Company Structure Details

  • Legal name: BioCorRx
  • Sector: Healthcare
  • Industry: Specialized Health Services
  • Full Time Employees: 4
  • Public Company: SEC Reporting and fully audited
  • Symbol: BICX
  • Exchange: OTCBB
  • Outstanding: 117,800,000
  • Authorized: 200,000,000
  • CUSIP: 35804J102
  • NAICS Code: 623220
  • SIC Number: 8093
  • Transfer Agent: Columbia Stock Transfer Company, 1869 E. Seltice Way #292, Post Falls, ID 83854 Tel (208) 664-3544
  • CIK: 0001443863
  • EIN: 26-1972677
  • Year End: December 31
  • State of incorporation: Nevada
  • Products: Alcohol rehabilitation, exclusive naltrexone implant technology
  • Address: 601 North Parkcenter Drive, Suite 103, Santa Ana, CA 92705 USA
  • Investors: 858-381-4677
  • Email: investors@biocorrx.com
  • Website: www.biocorrx.com

 



CEYY Chart

Key Executives

Kent Emry - CEO, Director
Brady Granier -COO, Director
Lourdes Felix -CFO, Director
Dr. Jorge Andrade, Jr. - Director
Neil Muller -Co-Founder and President, Director 

Locations
Locations of independently owned clinics using our Fresh Start Program

Start Fresh Recovery
720 N. Tustin Ave.
Suite 206
Santa Ana, CA 92705
714-541-6100
800-916-1099
www.startfreshrecovery.com 
www.stopdrinkingUSA.com

Start Fresh Executive Recovery
367 E Virginia Ave
Phoenix, AZ 85004
855-393-HOPE (4673)
www.ExecutiveRecovery.net 

Fresh Start Private Florida
1415 Panther Lane
Suites 313-320
Naples, FL 34109
800-985-7574
www.FreshStartPrivateFlorida.com 

Start Fresh Alcohol Recovery Center
2827 S. 88th St
Omaha NE 68124
402-884-1221
www.startfreshNE.com

Coming Soon!

• San Francisco, California
• Chandler, Arizona
• North Scottsdale, Arizona
• Connecticut

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BICX
Current Price
Volume:
Bid Ask Day's Range
Wiki
News News Alert: Current Report Filing (8-k) 09/30/2014 06:02:55 AM
PostSubject
#4268  Sticky Note SmallCapVoice Interview with Brady Granier(COO)and Jeremy Miller Interview Pip611 10/26/13 06:31:25 PM
#6399   Level 2? anyone ? Pip !! DREAM BIG 09/30/14 09:59:55 AM
#6398   NOOOO !!! They changed / added stuff to DREAM BIG 09/30/14 09:58:59 AM
#6397   So what does this mean? BICX no longer stenz902 09/30/14 09:53:41 AM
#6396   Current Report Filing (8-k) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Wa DREAM BIG 09/30/14 07:17:59 AM
#6395   IMO, someone put in a market order but Fido 09/29/14 03:37:19 PM
#6394   Now that certain director is back on the Pip611 09/29/14 03:17:22 PM
#6393   0.1549 got hit !!! DREAM BIG 09/29/14 03:16:06 PM
#6392   looks like some nice steady accumulation over the Pip611 09/29/14 03:09:13 PM
#6391   0.14 on the ask !!!! Go BICX DREAM BIG 09/29/14 02:59:33 PM
#6390   http://www.radioamerica.org/POD_hff.htm DREAM BIG 09/28/14 09:03:29 PM
#6389   9/26/2014 Crack-smoking Toronto mayor bets re-election on alcoholism rehab DREAM BIG 09/26/14 03:18:44 PM
#6388   I Agree..:+) inet 09/26/14 02:47:33 PM
#6387   Lucky him ;) DREAM BIG 09/26/14 02:26:18 PM
#6386   Someone must have snatched up those 130k shares inet 09/26/14 01:56:24 PM
#6385   http://m.seekingalpha.com/instablog/28067573-adbeeston/3304365-how-to-spot-if-a- DREAM BIG 09/26/14 12:57:04 PM
#6384   http://m.seekingalpha.com/instablog/28072273-dom-einhorn01/3304325-how-to-preven DREAM BIG 09/26/14 12:56:09 PM
#6383   Moving UPPPPP:) DREAM BIG 09/26/14 11:39:40 AM
#6382   I'm wondering since Naltrexone has such a broad inet 09/26/14 09:21:16 AM
#6381   New FDA-Approved Weight Loss Pill Has Anti-Addiction Drug DREAM BIG 09/26/14 08:53:47 AM
#6380   Thanks for the reply, much appreciated. I'm mackzoo63 09/26/14 12:24:20 AM
#6379   Fido, Thanks for the reply and clearing that up mackzoo63 09/26/14 12:22:42 AM
#6378   This is about a certain BICX director, who Pip611 09/25/14 05:18:28 PM
#6377   mackzoo63, this is for BICX. I too Fido 09/25/14 04:50:12 PM
#6376   Sorry if I mis-read the thread, I have mackzoo63 09/25/14 04:43:56 PM
#6375   Thanks for the input! :+) inet 09/25/14 04:25:19 PM
#6374   He is not involved in the decision making DREAM BIG 09/25/14 04:11:30 PM
#6373   If you look back at the filings that Pip611 09/25/14 03:28:49 PM
#6372   Why is it this certain Board member keeps inet 09/25/14 03:17:13 PM
#6371   Insider sold 130,000 shares (Dr. Jorge Andrade). I itsdetatti 09/24/14 07:47:04 PM
#6370   The way this stock is dropping there must big orange 09/24/14 06:01:08 PM
#6369   Good Volume today, just in the wrong direction. inet 09/24/14 05:36:57 PM
#6367   Man I wish we could get on a inet 09/22/14 05:33:15 PM
#6366   Really like your post Dream, but I just itsdetatti 09/22/14 11:03:19 AM
#6365   Teens risk brain damage, low IQ from weekly DREAM BIG 09/22/14 09:33:44 AM
#6364   Cincinnati researchers call for more research on opioid DREAM BIG 09/22/14 08:42:17 AM
#6363   I 100% agree, this little guy is going inet 09/19/14 09:17:52 AM
#6362   I suspect that is one of the three Fido 09/18/14 06:47:17 PM
#6361   2nd day in a Row .... NEWS 9/18/2014 DREAM BIG 09/18/14 08:46:35 AM
#6360   The natural response to great news, such as itsdetatti 09/17/14 05:36:27 PM
#6359   Might help if Board member Andrade would quit JB51 09/17/14 04:29:36 PM
#6358   It does look like someone is heading for Fido 09/17/14 02:08:13 PM
#6357   Agreed however even it was just 20 going autobob 09/17/14 01:58:08 PM
#6356   It would be nice to have seen the Fido 09/17/14 08:50:34 AM
#6355   NEWS 9/17/2014 DREAM BIG 09/17/14 08:10:55 AM
#6354   Gumint would help if the ACA is going Fido 09/16/14 07:01:28 PM
#6353   9/16/2014 Better strategies needed to prevent injured workers from DREAM BIG 09/16/14 08:25:28 AM
#6352   9/12/2014 Inmates Entering Ohio Prisons for Crimes Linked to DREAM BIG 09/12/14 08:28:27 AM
#6351   9/12/2014 DEA Publishes Final Rule on Hydrocodone Rescheduling, Met DREAM BIG 09/12/14 08:25:46 AM
#6350   Somebody must be desperate for a few dollars. Fido 09/10/14 01:30:31 PM
#6349   Hope so cause the Bid just fell to .089 autobob 09/10/14 01:12:06 PM
PostSubject